BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191028
DTEND;VALUE=DATE:20191029
DTSTAMP:20191020T223743Z
CREATED:20191020T223743Z
LAST-MODIFIED:20191020T223743Z
UID:31050-1572220800-1572307199@globalbiodefense.com
SUMMARY:DARPA Proposers Day: Nucleic Acids On-Demand Worldwide (NOW)
DESCRIPTION:The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) will host a Proposers’ Day on October 28\, 2019 in Arlington\, Virginia. \nThe event will gather the planned proposer community in support of the Nucleic Acids On-Demand Worldwide (NOW) program\, which aims to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to rapidly produce\, formulate\, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA). \nThe Proposers Day will include brief overview presentations by government personnel\, an\ninformation session to respond to questions from participants\, “lightning” talks (three minutes\,\none PowerPoint slide)\, posters for potential proposers to highlight technical capabilities or to\npromote teaming\, and private sidebar meetings between the DARPA government team and\npotential proposer teams. \nParticipant presentations and sidebar meetings must be scheduled via the registration website. Lightning talk presentations will be made accessible to the proposer community on the NOW program website after presentation at the Proposers day. It is expected that NOW will require strong teaming efforts to successfully innovate and integrate critical technologies necessary to meet the metrics of the NOW program. \nAttendance at this event is not a requirement for submission of a proposal or selection for\nfunding. Information relayed during the Proposers Day will be made available on the BTO\nsection of the DARPA Opportunities page. \nAttendance is open to individuals who are U.S. Citizens\, U.S. Permanent Residents\, and Foreign Nationals. Upon entry to the physical meeting\, all attendees will be required to present valid\, Government-issued photo identification. \nREGISTER HERE. Registration for physical participation will close on October 23\, 2019 at 12:00 PM ET (updated from original date of October 21\, 2019 at 12:00 PM ET) or when capacity is reached and webinar participation will close on October 25\, 2019 at 12:00 PM ET or when webinar capacity is reached\, whichever comes first.Registration is limited by the venue capacity\, and early registration is strongly recommended. There will be no on-site registration. \nGlobal Biodefense is a publisher providing visibility on this important development program. For all attendance or logistics information\, please contact the event sponsor.
URL:https://globalbiodefense.com/event/darpa-proposers-day-nucleic-acids-on-demand-worldwide-now/
LOCATION:Executive Conference Center (ECC)\, 4075 Wilson Boulevard\, Arlington\, VA\, 22203\, United States
CATEGORIES:Industry Day,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191121T090000
DTEND;TZID=America/New_York:20191121T103000
DTSTAMP:20191115T041744Z
CREATED:20191115T041446Z
LAST-MODIFIED:20191115T041744Z
UID:33870-1574326800-1574332200@globalbiodefense.com
SUMMARY:All of Us: How Public Health Can Learn From and Inform the Precision Medicine
DESCRIPTION:The Office of Genomics and Precision Public Health\, Office of Science\, Centers for Disease Control and Prevention will host a Webinar on 21 Nov 2019 on the All of Us research program. \nThe National Institute of Health (NIH)-led All of Us research program aims to enroll over one million people in the U.S. in a research cohort to improve understanding of how individual differences in lifestyle\, socioeconomics\, environment\, and biology affect health outcomes. \nRecruiting a diverse research cohort is key to ensuring that findings will be broadly applicable\, and All of Us strives to include participants from groups historically underrepresented in biomedical research. Join us to learn more about the All of Us research program\, better understand how the approaches used to recruit All of Us participants can inform future public health efforts to address diversity\, and share your expertise in increasing diverse participation in your own public health work. \nFree Online Webinar\nRegistration is required. Please register.\nView the Webinar via Skype\nPhone: (855) 644-0229\, Conference ID: 4390261
URL:https://globalbiodefense.com/event/all-of-us-how-public-health-can-learn-from-and-inform-the-precision-medicine/
LOCATION:Centers for Disease Control and Prevention\, 1600 Clifton Road\, Atlanta\, GA\, 30329\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191121T140000
DTEND;TZID=America/New_York:20191121T153000
DTSTAMP:20190927T181033Z
CREATED:20190927T181033Z
LAST-MODIFIED:20190927T181033Z
UID:30701-1574344800-1574350200@globalbiodefense.com
SUMMARY:Ebola and Beyond: Legal Preparedness for Outbreaks
DESCRIPTION:A webinar on the Legal Preparedness for Outbreaks will be held 21 Nov 2019 at 2:00pm Eastern. \nThe discussion will examine challenges public health professionals and responders are facing during the Ebola response\, as well as current legal provisions and concepts and how to apply them to future infectious disease emergency response planning. In addition\, as studies show vulnerable populations are the most significantly impacted when disasters strike\, this webinar will highlight protection of vulnerable populations for the next communicable disease outbreak of public health concern. \nThe webinar is the 3rd in a 4-part series on Legal Preparedness for Public Health Emergencies hosted under a collaborative effort by the National Governors Association\, U.S. Centers for Disease Control and Prevention and the American Bar Association. \nRegister here.
URL:https://globalbiodefense.com/event/ebola-and-beyond-legal-preparedness-for-outbreaks/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191204
DTEND;VALUE=DATE:20191205
DTSTAMP:20191204T193020Z
CREATED:20191102T054424Z
LAST-MODIFIED:20191204T193020Z
UID:34810-1575417600-1575503999@globalbiodefense.com
SUMMARY:Personalized Protective Biosystem (PPB) Proposers Day
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day meeting and webinar covering the new Personalized Protective Biosystem (PPB) program on Dec 4\, 2019 in Arlington\, Va. \nPPB aims to develop technology that reduces the need for burdensome protective equipment while increasing individual protection against chemical and biological threats. The program comprises two technical areas: 1) reactive materials that prevent threat agent access to the body; 2) a configurable barrier countermeasure that neutralizes threat agents at vulnerable points of entry (i.e.\, skin\, airway\, ocular). \nAdditional details\, including registration instructions\, are available at https://go.usa.gov/xp8dU. The registration deadline is November 26\, 2019\, at 12:00 PM EST or when capacity is reached. Registrations for webinar attendance only are accepted through December 2\, 2019\, or until webinar capacity is reached. \nDARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore\, the PPB Proposers Day is open only to registered potential applicants\, and not to the media or general public. \nDARPA anticipates sharing additional program details in a forthcoming Broad Agency Announcement to be posted to the https://beta.sam.gov/ website.
URL:https://globalbiodefense.com/event/personalized-protective-biosystem-ppb-proposers-day/
LOCATION:George Mason University Arlington Campus\, 3351 Fairfax Dr\, Arlington\, VA\, 22201\, United States
CATEGORIES:Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/12/cbrne-darpa-ppb-personalized-protective-biosystem.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200123
DTEND;VALUE=DATE:20200125
DTSTAMP:20200105T182855Z
CREATED:20191205T175457Z
LAST-MODIFIED:20200105T182855Z
UID:36104-1579737600-1579910399@globalbiodefense.com
SUMMARY:National Science Advisory Board for Biosecurity (NSABB) Meeting
DESCRIPTION:The National Science Advisory Board for Biosecurity (NSABB) will convene 23-24 January 2020 in Bethesda\, Md. \nThe meeting will be open to the public\, with attendance limited to space available. The meeting will also be videocast. \nJanuary 23: 12:30 PM – 5 PM Eastern\nJanuary 24: 9 AM – 2:30 PM Eastern \nThe purpose of this meeting is to discuss considerations regarding security and public transparency when sharing information about research involving enhanced potential pandemic pathogens; as well as other business of the Board. \nIf you plan to attend the meeting in person please pre-register HERE.\nIndividuals in attendance may also register onsite on the day of the meeting.\nDraft Agenda will be posted when available. \nVideocasts: \n\nDay 1 – Link will be available on January 23\, 2020\nDay 2 – Link will be available on January 24\, 2020\n\nPlease visit the website for more information: http://bit.ly/NSABB-Meetings \nCurrent Voting Board Members\nMargie D. Lee\, DVM\, PhD*\nProfessor and Head\, Department of Biomedical Sciences and Pathobiology\nVirginia-Maryland College of Veterinary Medicine\nVirginia Tech \nStephen S. Morse\, PhD*\nDirector\, Infectious Disease Epidemiology Certificate Program\nProfessor of Epidemiology\nMailman School of Public Health\nColumbia University \nJean L. Patterson\, PhD\nProfessor\, Virology and Immunology Chair\, BSL-4 Task Force\nTexas Biomedical Research Institute \nRozanne M. Sandri-Goldin\, PhD\nProfessor and Chair\, Department of Microbiology and\nMolecular Genetics\nUniversity of California Irvine School of Medicine \nKenneth Bernard\, MD\nRADM\, U.S. Public Health Service (Ret.)\nFormer Special Assistant to the President for Biodefense\, Homeland Security Council\, White House\nFormer Special Adviser for Health and Security on the National Security Council \nCraig E. Cameron\, PhD\nJeffrey Houpt Distinguished Investigator\nChair\, Department of Microbiology and Immunology\nUniversity of North Carolina Chapel Hill School of Medicine \nMark Denison\, MD\nProfessor and Chair of Pediatrics\nAssociate Professor of Microbiology and Immunology\nVanderbilt University School of Medicine \nJohn D. Grabenstein\, RPh\, PhD\nSenior Medical Director\, Adult Vaccines\nMerck Vaccine Division\nMerck & Co.\, Inc. \nMarie-Louise Hammarskjöld\, MD\, PhD\nCharles H. Ross Jr. Professor and Professor of Microbiology\, Immunology\, and Cancer Biology\nAssociate Director\, Myles H. Thaler Center\nUniversity of Virginia School of Medicine \nJames W. LeDuc\, PhD\nDirector\, Galveston National Laboratory\nProfessor\, Department of Microbiology and Immunology\nUniversity of Texas Medical Branch
URL:https://globalbiodefense.com/event/national-science-advisory-board-for-biosecurity-nsabb-meeting/
LOCATION:Hyatt Regency Bethesda\, One Bethesda Metro Center\, Bethesda\, MD\, 20814\, United States
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200126T110000
DTEND;TZID=America/New_York:20200126T140000
DTSTAMP:20201127T192409Z
CREATED:20201127T192409Z
LAST-MODIFIED:20201127T192409Z
UID:48057-1580036400-1580047200@globalbiodefense.com
SUMMARY:Envisioning a Transformed Clinical Trials Enterprise for 2030
DESCRIPTION:The National Academies’ Forum on Drug Discovery\, Development\, and Translation will host a virtual public workshop on Jan 26\, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally. \nThis virtual public workshop will provide a venue for stakeholders to consider a transformed clinical trial enterprise for 2030. Workshop participants will consider lessons learned from progress and setbacks over the past 10 years\, since the previous workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States\, and\, looking forward\, discuss goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030. \nThe event will provide an overview discussion on how an envisioned 2030 clinical trials enterprise may differ from the current system. It will discuss key challenges and opportunities in improving person-centeredness and inclusivity\, building resilience and transparency\, and integrating new technologies. \nThe workshop session will consider changes in the clinical trials enterprise made in response to COVID-19 that may establish positive and sustainable examples for the future\, and consider specific action steps that individual stakeholders could take to support an envisioned change from 2020 to 2030. \nFor additional information on the workshop series\, please visit the project page. \nBackground\nClinical trials research has changed dramatically over the last decade. The biological\, physical\, and digital spheres are merging; clinical research and health care are at a critical juncture; new approaches enable the collection of data in real-world settings; and new modalities\, such as digital health technologies and artificial intelligence applications\, are changing possibilities for the conduct of clinical research. These opportunities hold great promise for advancing our understanding of health maintenance and prevention\, disease progression\, and developing new therapies for patients. At the same time\, the clinical research enterprise is strained by rising costs\, an evolving regulatory and economic landscape\, increasing clinical trial complexity\, difficulties in the recruitment and retention of research participants\, and a clinical research workforce that is under tremendous stress. Some\, but not all\, of these challenges and opportunities were predicted in the 2011 National Academies workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020. There is now a need for stakeholders from across the clinical research lifecycle to consider lessons learned from progress and setbacks over the past 10 years and broadly consider goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030.
URL:https://globalbiodefense.com/event/envisioning-a-transformed-clinical-trials-enterprise-for-2030/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://bit.ly/nasem-clinicaltrialenterprise
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200127T140000
DTEND;TZID=America/New_York:20200127T150000
DTSTAMP:20200126T224608Z
CREATED:20200124T185703Z
LAST-MODIFIED:20200126T224608Z
UID:37773-1580133600-1580137200@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \n(h/t NACCHO for originally posting this information.)
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness/
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200128
DTEND;VALUE=DATE:20200130
DTSTAMP:20191227T191045Z
CREATED:20191127T185911Z
LAST-MODIFIED:20191227T191045Z
UID:36001-1580169600-1580342399@globalbiodefense.com
SUMMARY:Tick-Borne Disease Working Group (TBDWG)
DESCRIPTION:The 11th meeting of the Tick-borne Disease Working Group (TBDWG) will be held on January 28 and 29\, 2020\, from 9:00 a.m. to 4:30 p.m. ET on both days (times subject to change). \nThe meeting will be held at the in Washington D.C. and by webcast. Preregistration for public members is advisable and can be accomplished by registering here. \nThe TBDWG was established by Congress in 2016 as part of the 21st Century Cures Act to provide subject matter expertise and to review federal efforts related to all tick-borne diseases\, to help ensure interagency coordination and minimize overlap\, and to examine research priorities.  The focus of this effort is the development of a report to the Secretary of Health and Human Services and Congress on the findings and any recommendations of the Working Group for the federal response to tick-borne disease prevention\, treatment and research\, as well as how to address gaps in these areas. \nFor this meeting\, the Working Group will hear presentations from eight subcommittees on their findings and potential actions for the TBDWG to consider; hear updates from the Public Comment and Inventory Subcommittees; and further discuss plans for developing the 2020 report to the HHS Secretary and Congress on federal tick-borne activities and research. \nPublic Comment – Information and Instructions\nThe public will have an opportunity to present their views to the Working Group during the meeting’s public comment session or by submitting their views in writing. \nVerbal comments (in-person): \n\nRequests to provide verbal public comment must be submitted via email by midnight Tuesday\, January 17\, 2020\, ET to tickbornedisease@hhs.gov. In the Subject line please enter: Verbal Public Comment – January 28-29 Meeting. In addition\, please indicate if you will be providing verbal comment in person or by phone. If by phone\, you will be provided a call-in number and and time to call.\nA total of 30 minutes has been set aside for verbal comments on both days. Each person will be limited to 3 minutes in order to accommodate as many speakers as possible. If more requests are received than can be accommodated\, speakers will be randomly selected.\nYour remarks will be heard over a live webcast and will become part of the archived recording and meeting summary that will be posted on this website.\n\nWritten comments \n\nWritten public comments must be submitted via email by midnight Tuesday\, January 17\, 2020\, ET to tickbornedisease@hhs.gov. In the Subject line please enter: Written Public Comment – January 28-29 Meeting.\nWhen you submit your written comment\, please include a statement letting the TBDWG know how you would like to be identified with your comment. You may choose to use your name or to be anonymous. You may also list your city and/or state. If you are providing comments on behalf of an organization\, please include the name of the organization. TBDWG cannot post your comment until you let us know how you would like to be identified.\nComments should either be provided in the body of your email\, or in an attachment in Word format and equivalent to no more than 4 pages in Calibri or Times New Roman\, 11 point font. Text that exceeds the 4 pages will be deleted.\nTBDWG will not post graphics\, images\, text boxes\, or tables. If included with your comment\, they will not be able to retain them.\nTBDWG can only create hyperlinks to “.gov” sites (local\, state\, or federal). For all other reference sites\, please insert the full URL (e.g.\, http://learn.genetics.utah.edu/content/epigenetics).\nTBDWG is also unable to include attachments as supporting documentation to your written comments.\n\n\n\n\nAgenda\nDraft agenda – subject to change. \nDay 1 – January 28\, 2020 \n\n\n\nTime\nAgenda Item\nSpeaker\n\n\n\n\n9:00 am – 9:05 am\n– Welcome from the Working Group\n– Roll Call: During roll call members are asked to state their organization and what subcommittee(s) they co-chair\nLeigh Ann Soltysiak\, Co-Chair\nDavid Walker\, Co-Chair\nJim Berger\, DFO\n\n\n9:05 am – 9:07 am\nOverview of the Working Group’s Mission\, Vision Statement\, Values\nJim Berger\, DFO\n\n\n9:07 am – 9:10 am\n– Update from September 12\, 2019\, Meeting to Today\n– Review 2020 TBDWG objectives\n– What We Hope to Accomplish Today\n– Introduction of Speakers\nLeigh Ann Soltysiak\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n9:15 am – 9:20 am\n– NIH Strategic Plan Update\n– CDC-led Domestic Framework\nSam Perdue\nBen Beard\n\n\n9:20 am – 9:50 am\nPublic Comments\n–\n\n\n9:50 am – 10:00 am\nPublic Comment Subcommittee Update\n– Comments received\n– Overall themes\nScott Commins\, Co-Chair\nAngel Davey\, Co-Chair\nLeigh Ann Soltysiak\, Co-Chair\n\n\n10:00 am – 11:00 am\nSubcommittee Presentation – Tick Biology\, Ecology\, and Control Subcommittee\nKevin Macaluso\, Co-Chair\nBeto Perez de Leon\, Co-Chair\n\n\n11:00 am – 11:15 am\nBreak\n–\n\n\n11:15 am – 12:15 pm\nSubcommittee Presentation – Pathogenesis and Physiology of Lyme Disease Subcommittee\nSam Donta\, Co-Chair\nLeith States\, Co-Chair\n\n\n12:15 pm – 1:15 pm\nSubcommittee Presentation – Clinical Aspects of Lyme Disease Subcommittee\nCDR Rebecca Bunnell\, Co-Chair\nSam Donta\, Co-Chair\n\n\n1:15 pm – 2:15 pm\nLunch\n–\n\n\n2:15 pm – 3:15 pm\nSubcommittee Presentation – Training\, Education\, Access to Care\, and Reimbursement Subcommittee\nCDR Rebecca Bunnell\, Co-Chair\nPat Smith\, Co-Chair\n\n\n3:15 pm – 4:15 pm\nSubcommittee Presentation – Alpha-gal Subcommittee\nScott Commins\, Co-Chair\nAngel Davey\, Co-Chair\nLeigh Ann Soltysiak\, Co-Chair\n\n\n4:15 pm\nAdjourn\n–\n\n\n\nDay 2 – January 29\, 2020 \n\n\n\nTime\nAgenda Item\nSpeaker\n\n\n\n\n9:00 am – 9:05 am\nWelcome from the Working Group\nLeigh Ann Soltysiak\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n9:05 am – 9:07 am\nRecap of First Day\nJim Berger\, DFO\n\n\n9:07 am – 9:37 am\nPublic Comments\n–\n\n\n9:37 am – 10:37 am\nSubcommittee Presentation – Babesiosis and Tick-Borne Pathogens Subcommittee\nBen Beard\, Co-Chair\nGene Shapiro\, Co-Chair\n\n\n10:37 am – 10:52 am\nBreak\n–\n\n\n10:52 am – 11:52 am\nSubcommittee Presentation – Ehrlichiosis and Anaplasmosis Subcommittee\nDennis Dixon\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n11:52 am – 12:52 pm\nSubcommittee Presentation – Rickettsiosis Subcommittee\nEstella Jones\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n12:52 pm – 1:52 pm\nLunch\n–\n\n\n1:52 pm – 1:57 pm\nFederal Inventory Update\n– What has been received\n– What is outstanding\nJim Berger\, DFO\n\n\n1:57 pm – 3:07 pm\nOpen Discussions for Working Group\nWorking Group\n\n\n3:07 pm – 3:22 pm\nBreak\n–\n\n\n3:22 pm – 3:52 pm\nDiscussion of Next Steps and What is Expected for the March Meeting\nLeigh Ann Soltysiak\, Co-Chair\nDavid Walker\, Co-Chair\n\n\n3:52 pm – 3:57 pm\nReview Draft Outline of Report to Congress\nWorking Group\n\n\n3:57 pm – 4:30 pm\nOpen Discussion for Working Group\nWorking Group\n\n\n4:30 pm\nAdjourn\n–\n\n\n\nPlease view the Federal Register Meeting Notice and visit the meeting page for the latest information. \n 
URL:https://globalbiodefense.com/event/tick-borne-disease-working-group-tbdwg/
LOCATION:Hyatt Place Washington DC/US Capitol\, 33 New York Avenue\, Washington\, DC\, 20002\, United States
CATEGORIES:Policy-Legislative,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2014/05/tick_amber_ancient_lyme.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200131T140000
DTEND;TZID=America/New_York:20200131T150000
DTSTAMP:20200131T163844Z
CREATED:20200131T143313Z
LAST-MODIFIED:20200131T163844Z
UID:37932-1580479200-1580482800@globalbiodefense.com
SUMMARY:CDC COCA Call: Outbreak of 2019-nCoV: Interim Guidance for Clinicians
DESCRIPTION:The CDC will hold a COCA (Clinicians Outreach and Communication Activity) call this afternoon with their latest recommendations. \n\nDue to the high demand we anticipate for this COCA Call\, we kindly ask participants to access it in a group format\, if at all possible\, to allow for the maximum number of participants to attend. \nTarget audience: \n\nPhysicians\nNurses\nPharmacists\nVeterinarians\nPhysician Assistants\nHealth Educators\nOther Clinicians\n\nPlease note\, there will be only a few introductory slides for this presentation. The subject matter covered during this webinar will not have an accompanying slide deck. \n\nContact Information:coca@cdc.gov\nSupport/Funding:Centers for Disease Control and Prevention\, Emergency Risk Communication Branch\n\nPRESENTERS \nAron Hall\, DVM\, MSPH\n2019-nCoV Epidemiology Task Force Deputy Lead\nNational Center for Immunization and Respiratory Diseases\nCenters for Disease Control and Prevention \nWill Weldon\, PhD\n2019-nCoV Laboratory Task Force Lead\nNational Center for Immunization and Respiratory Diseases\nCenters for Disease Control and Prevention \nTimothy Uyeki\, MD\, MPH\, MPP\n2019-nCoV Response Clinical Team Lead\nNational Center for Immunization and Respiratory Diseases\nCenters for Disease Control and Prevention \nRyan Fagan\, MD\, MPH&TM\n2019-nCoV Healthcare Infection Control Team Lead\nNational Center for Emerging and Zoonotic Infectious Diseases\nCenters for Disease Control and Prevention \nPlease visit the website for call-in information
URL:https://globalbiodefense.com/event/cdc-coca-call-outbreak-of-2019-ncov-interim-guidance-for-clinicians/
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200203T140000
DTEND;TZID=America/New_York:20200203T150000
DTSTAMP:20200126T190909Z
CREATED:20200126T190529Z
LAST-MODIFIED:20200126T190909Z
UID:37776-1580738400-1580742000@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-2/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200206T173000
DTEND;TZID=America/New_York:20200206T190000
DTSTAMP:20200206T190217Z
CREATED:20200203T163455Z
LAST-MODIFIED:20200206T190217Z
UID:38437-1581010200-1581015600@globalbiodefense.com
SUMMARY:Yale Forum on Outbreak of Novel Coronavirus
DESCRIPTION:In response to news and concerns about the respiratory illness outbreak caused by a novel coronavirus initially identified in China\, the Yale Institute for Global Health\, Yale School of Public Health and the Global Health Justice Partnership will hold a discussion and question and answer session on Thursday\, February 6\, 2020. Panelists will address the epidemiology of the disease\, its impact on public health\, human rights issues and how information on such outbreaks is communicated to the public.\n\nModerator \nSaad Omer\, Director\, Yale Institute for Global Health; Professor of Medicine (Infectious Diseases)\, Yale School of Medicine; Susan Dwight Bliss Professor of Epidemiology of Microbial Diseases\, Yale School of Public Health \nPanelists \nEllen Foxman\, Assistant Professor of Laboratory Medicine and Immunobiology\, Yale School of Medicine \nGregg Gonsalves\, Assistant Professor of Epidemiology; Associate (Adjunct) Professor of Law\, Yale Law School; Co-Director\, Global Health Justice Partnership \nNathan Grubaugh\, Assistant Professor of Epidemiology (Microbial Diseases)\, Yale School of Public Health \nLisa Sanders\, Associate Professor of Medicine (General Medicine)\, Yale School of Medicine; Emmy-award winning television producer\, author of The New York Times column Diagnosis \nDavid Vlahov\, Professor\, PhD Program Director\, Yale School of Nursing \nLive Stream Link \nhttps://yale.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=50702300-d8eb-4398-9d9e-ab530102bbbe
URL:https://globalbiodefense.com/event/yale-forum-on-outbreak-of-novel-coronavirus/
LOCATION:Winslow Auditorium\, 60 College Street\, LEPH 109\, New Haven\, CT\, 06510\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200210T133000
DTEND;TZID=America/New_York:20200210T153000
DTSTAMP:20200203T162053Z
CREATED:20200203T161203Z
LAST-MODIFIED:20200203T162053Z
UID:38397-1581341400-1581348600@globalbiodefense.com
SUMMARY:Containing the Coronavirus: Challenges to Thwarting the Outbreak
DESCRIPTION:Hudson Institute and the Bipartisan Commission on Biodefense will host a panel discussion on the ongoing coronavirus outbreak and how the United States can respond to the growing outbreak effectively. \nConfirmed infections of the coronavirus in China have exceeded that of the 2002-2003 SARS epidemic\, with thousands more suspected cases. As the number of cases increases\, concerns are mounting that the global community may not be adequately prepared to prevent the disease from significantly spreading. \nThe virus has already spread to more than 20 countries\, including the United States\, with at least six confirmed cases and more than 100 suspected across 36 states. The Center for Disease Control (CDC) is screening passengers arriving from China at several airports\, but much remains unknown about transmission and symptoms\, and a CDC-developed diagnostic test has yet to be distributed across the country. \nPanel participants will offer their perspectives on the role of the federal government in managing the crisis\, the lack of transparency by the Communist Chinese Government\, implications for U.S national security\, and how the country can better prepare for when the next pandemic strikes. \nThe event will feature U.S. Senator Joe Lieberman\, co-chair of the Bipartisan Commission on Biodefense\, scholars from Hudson Institute\, and other subject matter experts. \nNOTE: This event is open to the press. All members of the media should RSVP to press@hudson.org.
URL:https://globalbiodefense.com/event/containing-the-coronavirus-challenges-to-thwarting-the-outbreak/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200210T140000
DTEND;TZID=America/New_York:20200210T150000
DTSTAMP:20200126T190837Z
CREATED:20200126T190718Z
LAST-MODIFIED:20200126T190837Z
UID:37779-1581343200-1581346800@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-3/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200219T150000
DTEND;TZID=America/New_York:20200219T160000
DTSTAMP:20200208T165510Z
CREATED:20200208T165105Z
LAST-MODIFIED:20200208T165510Z
UID:39162-1582124400-1582128000@globalbiodefense.com
SUMMARY:Public Health Emergency Preparedness (PHEP) Monthly Call
DESCRIPTION:PHEP Recipient Monthly Conference Call Scheduled for February 19 \nCDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday\, February 19. Participant information is provided below. \n  \nConference Call Information \nBridge Line: (888) 566-1873 \nParticipant Code: 3358383 \n  \nThe Public Health Emergency Preparedness (PHEP) cooperative agreement is a critical source of funding for state\, local\, and territorial public health departments. Since 2002\, the PHEP cooperative agreement has provided assistance to public health departments across the nation. This helps health departments build and strengthen their abilities to effectively respond to a range of public health threats\, including infectious diseases\, natural disasters\, and biological\, chemical\, nuclear\, and radiological events. Preparedness activities funded by the PHEP cooperative agreement specifically targeted the development of emergency-ready public health departments that are flexible and adaptable.
URL:https://globalbiodefense.com/event/public-health-emergency-preparedness-phep-monthly-call/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200224T140000
DTEND;TZID=America/New_York:20200224T150000
DTSTAMP:20200126T214159Z
CREATED:20200126T193833Z
LAST-MODIFIED:20200126T214159Z
UID:37781-1582552800-1582556400@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-4/
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200226
DTEND;VALUE=DATE:20200227
DTSTAMP:20200206T192309Z
CREATED:20200206T191959Z
LAST-MODIFIED:20200206T192309Z
UID:38920-1582675200-1582761599@globalbiodefense.com
SUMMARY:Emerging Bioethical Issues in Biomedical Research: A Workshop
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine will conduct a one day workshop on Feb 26\, 2020 to bring together stakeholders to discuss potential ethical issues that may arise from new and emerging trends in biomedical research (including behavioral and social research) and society. \nThe workshop will identify a range of current and emerging bioethical issues – both in basic and clinical research – and explore a broad-range of stakeholder perspectives. Input will be sought from a variety of perspectives which may include patients/participants/individuals\, bioethicists\, academic and industry researchers\, clinicians\, and government representatives. The workshop will describe the state of the emerging science and potential pressing\, recurring\, emerging\, and/or anticipated future bioethical issues in biomedical research and society that fall within the scope of the research and policy activities of the NIH. Potential topics may include: \n\nUse of digital technologies\, artificial intelligence\, and machine learning in biomedical research and clinical care;\nEmerging ethical challenges for sharing data from human research participants and use of human biospecimens;\nHealth equity and health disparities in research\, including:\n\nRecognizing and addressing barriers to participation in research and clinical care across diverse populations and groups\nUnderstanding the impact of cultural and social context on health and disease\nEquitable distribution of the benefits and burdens of research;\n\n\nInnovative study designs\, including crowdsourcing of research and citizen science;\nNovel approaches for enhancing bioethics infrastructure and training;\nNew means for assessing and enhancing scientific workforce diversity; and/or\nInnovative solutions for enhancing research oversight infrastructure.\n\nGiven the broad scope of bioethical issues in research and the difficulty in addressing all possible issues in a single workshop\, the following topics fall outside the scope of this workshop as they are being addressed in multiple other venues: gene editing\, gene drives\, human-animal chimera research\, human fetal tissue research\, neuroethics\, and animal care and welfare. The planning committee will develop the agenda for the workshop\, select and invite speakers and discussants\, and moderate or identify moderators for the discussions. A workshop proceedings will be prepared by a designated rapporteur based on the information gathered and discussions held during the workshop in accordance with National Academies institutional policies and procedures. \nNote: Registration for in-person attendance is full. You may register for the webcast HERE. If you are interested in signing up for the in-person waitlist\, please register HERE and we will contact you if a spot becomes available.
URL:https://globalbiodefense.com/event/emerging-bioethical-issues-in-biomedical-research-a-workshop/
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200302T113000
DTEND;TZID=America/New_York:20200302T120000
DTSTAMP:20200301T230419Z
CREATED:20200301T230209Z
LAST-MODIFIED:20200301T230419Z
UID:40566-1583148600-1583150400@globalbiodefense.com
SUMMARY:COVID-19 Live Webcast with Johns Hopkins Experts
DESCRIPTION:With COVID-19 now spreading via community transmission in the U.S. and the World Health Organization raising its risk assessment to “very high\,” the Johns Hopkins Bloomberg School of Public Health will host a 30-minute webcast featuring some of the best minds addressing this global health concern. \nYou’ll hear from Dr. Jennifer Nuzzo and Dr. Tara Kirk Sell of the Johns Hopkins Center for Health Security and Lauren Sauer of the Johns Hopkins Office of Critical Event Preparedness and Response. The conversation will be moderated by Dr. Joshua Sharfstein\, Vice Dean of the Johns Hopkins Bloomberg School of Public Health and former secretary of Maryland’s Department of Health. \nThey’ll discuss the findings of the Global Health Security Index referenced by President Trump last week\, what you need to know about community transmission and how to protect yourself from misinformation. They will also answer viewer questions submitted before and during the broadcast. \nSpeakers\n\nJennifer Nuzzo\, DrPH\, SM\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nTara Kirk Sell\, PhD\, MA\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nLauren M. Sauer\, MS\nDirector of Operations\, Johns Hopkins Office of Critical Event Preparedness and Response\nJohns Hopkins University School of Medicine\nJosh Sharfstein\, MD\nModerator\nVice Dean for Public Health Practice and Community Engagement\nJohns Hopkins Bloomberg School of Public Health\n\nA recording will be made available via on The Hub’s dedicated coronavirus page at https://hub.jhu.edu/novel-coronavirus-information/ and across Bloomberg School channels. \nThe Johns Hopkins Bloomberg School of Public Health will host additional webcasts as the coronavirus outbreak continues. Follow us on Twitter\, Facebook\, LinkedIn\, and Instagram to be notified about future broadcasts. \nThe Bloomberg School is also launching a daily “Public Health On Call” podcast with an immediate focus on the coronavirus outbreak. Subscribe via YouTube or Libsyn.
URL:https://globalbiodefense.com/event/covid-19-live-webcast-with-johns-hopkins-experts/
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200302T140000
DTEND;TZID=America/New_York:20200302T150000
DTSTAMP:20200126T224530Z
CREATED:20200126T224350Z
LAST-MODIFIED:20200126T224530Z
UID:37784-1583157600-1583161200@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-5/
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200310T133000
DTEND;TZID=America/New_York:20200310T143000
DTSTAMP:20240623T230635Z
CREATED:20200305T230620Z
LAST-MODIFIED:20240623T230635Z
UID:40918-1583847000-1583850600@globalbiodefense.com
SUMMARY:Journalists Covering COVID-19: What Do You Need to Know
DESCRIPTION:Association of Health Care Journalists (AHCJ) members are invited to a special webcast event “Covering COVID-19: What Do You Need to Know?” on 10 March 2020. \nThe COVID-19 outbreak story is evolving quickly and there are many unknowns about the epidemic\, including how contagious the virus is\, its mortality rate and whether there is undetected spread occurring outside of China. Providing accurate information to the public is more important than ever in this moment of uncertainty. Hear a panel of infectious disease experts and a journalist explain what is known\, what to watch out for\, where to find trusted resources and how to combat misinformation and confusion. \n\nMaryn McKenna\, independent journalist\, author; Senior Fellow of the Center for the Study of Human Health at Emory University\nMichael Osterholm\, Ph.D.\, M.P.A.\, director\, Center for Infectious Disease Research and Policy\nSaskia Popescu\, senior infection preventionist\, ELBI Fellow and managing editor; HonorHealth\, Johns Hopkins Center for Health Security\, Pandora Report\nAngie Rasmussen\, Ph.D.\, Columbia University Mailman School of Public Health\, Associate Research Scientist\nModerator: Bara Vaida\, AHCJ core topic leader/infectious diseases\n\nSaskia Popescu is an experienced infectious disease epidemiologist and infection preventionist with a strong background in project management\, translation of complex issues into frontline applications\, and enhancing healthcare biopreparedness. She is passionate about healthcare biopreparedness\, antimicrobial resistance\, and driving change across sectors in global health security. \nAngie Rasmussen\, Ph.D.\, is an associate research scientist at Columbia University’s Mailman School of Public Health. She is a virologist studying host responses to infection by combining classical virology with modern systems biology approaches. Her research objectives are to identify host response signatures predictive of infection severity or disease outcome and host pathways to target drug development or repurposing. She is particularly interested in viruses that are highly pathogenic\, newly emergent or likely to emerge because of climate change\, land development\, or ecological disruption. \nMaryn McKenna is a journalist and book author and teaches health and science writing and storytelling\, and media literacy. She has reported from epidemics and disasters\, and farms and food production sites\, on most of the world’s continents\, including a field hospital in New Orleans during Hurricane Katrina\, to Midwestern farms devastated by the 2015 epidemic of avian flu. She writes for The New York Times Magazine\, The New Republic\, WIRED\, Smithsonian\, The Atlantic\, NPR\, and numerous other magazines and sites. She is the author of the 2017 bestseller Big Chicken: The Incredible Story of How Antibiotics Created Modern Agriculture and Changed the Way the World Eats (National Geographic Books\, Sept. 2017)\, which received the 2018 Science in Society Award\, making her a two-time winner of that prize. \nPlease visit the AHCJ’s Covering COVID-19: What Do You Need to Know event website for more information.
URL:https://globalbiodefense.com/event/journalists-covering-covid-19-what-do-you-need-to-know/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200318T100000
DTEND;TZID=America/New_York:20200318T154500
DTSTAMP:20200210T161026Z
CREATED:20200210T160543Z
LAST-MODIFIED:20200210T161026Z
UID:39238-1584525600-1584546300@globalbiodefense.com
SUMMARY:Next Evolution: Overhauling Key Elements of Biodefense
DESCRIPTION:The Bipartisan Commission on Biodefense will convene a meeting entitled ‘Next Evolution: Overhauling Key Elements of Biodefense‘ on March 18\, 2020 in Washington D.C. and made available by webcast. \nThis meeting aims to inform the assessment of biodefense programs with structural challenges that impede the government’s ability to safeguard the Nation. \nTopics to be discussed at this meeting include the: \n\nSelect Agent Program\nBioWatch Program\nHospital Preparedness Program\n\nSpeakers will share their perspectives\, experiences\, challenges\, and recommended solutions with regard to federal biodetection\, pathogen security\, and hospital preparedness programs. \nRegistration is required and attendance is free. \nWednesday\, March 18\, 2020 \n10:00 AM – 3:45 PM \nHudson Institute \n1201 Pennsylvania Avenue\, NW\, 4th floor \nWashington\, DC 20004 \nSee map \n  \n 
URL:https://globalbiodefense.com/event/next-evolution-overhauling-key-elements-of-biodefense/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200324
DTEND;VALUE=DATE:20200325
DTSTAMP:20200323T203331Z
CREATED:20191211T055500Z
LAST-MODIFIED:20200323T203331Z
UID:35083-1585008000-1585094399@globalbiodefense.com
SUMMARY:The Role of Digital Health Technologies in Drug Development - Webcast
DESCRIPTION:The Role of Digital Health Technologies in Drug Development: A Workshop will be webcast on March 24\, 2020. \nAs digital health technologies (e.g. smartphone apps\, wearables\, and mobile-device-based tools) – hardware and software – become increasingly available to consumers\, providers\, and researchers\, there are new opportunities to address critical barriers or “pain points\,” better connect patients and health care providers\, and incorporate patient input throughout the drug research and development (R&D) life cycle. However\, a lack of clarity when it comes to the evaluation\, selection\, and implementation of digital health technologies has impeded the practical application of these innovations. Lessons learned from the direct-to-consumer genomics industry\, which has been increasingly moving into the clinical health space over the last 10 years\, may help inform the integration of digital health technologies into drug R&D. \nThis workshop will provide a venue to discuss challenges and opportunities in digital health technologies for improving the probability of success in drug development and enabling precision medicine. Workshop participants may consider key components for an evidence-based framework for applying digital health technologies towards drug research and development. \nThe Forum on Drug Discovery\, Development\, and Translation and the Roundtable on Genomics and Precision Health will host a public workshop on March 24\, 2020 which will feature invited presentations and discussions to: \nDiscuss challenges/questions that digital health technologies may be uniquely suited to address and opportunities for digital health technologies to enable better patient care and more efficient clinical trials; \nConsider strategies for evaluating and selecting digital health technologies that are fit-for-purpose in drug development (e.g. establishing appropriate evidentiary criteria); \nDiscuss privacy\, ethical\, and regulatory issues related to the use of digital health technologies; \nExamine currently validated and/or FDA-approved drug development applications for digital health technologies; \nConsider opportunities to enable the practical application of digital health technologies for improving drug development (e.g. sharing best practices for the validation and use of digital health technologies\, harmonizing guidelines across sectors).
URL:https://globalbiodefense.com/event/the-role-of-digital-health-technologies-in-drug-development-webcast/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200324
DTEND;VALUE=DATE:20200326
DTSTAMP:20200323T210103Z
CREATED:20200319T205750Z
LAST-MODIFIED:20200323T210103Z
UID:42054-1585008000-1585180799@globalbiodefense.com
SUMMARY:BIO Coronavirus Collaboration Initiative Virtual Summit
DESCRIPTION:The Biotechnology Innovation Organization (BIO) is hosting a virtual summit to help companies working on COVID-19 treatments\, diagnostics and vaccines to come together to discuss challenges and opportunities with government officials and other stakeholders. \nThe two-day summit will take place on Tuesday\, March 24 and Wednesday\, March 25\, and will be led by BIO President and CEO Jim Greenwood and Dr. George Scangos\, President and CEO of Vir Biotechnology. BIO Board Chairman Dr. Jeremy Levin\, CEO of Ovid Therapeutics\, appointed Dr. Scangos to oversee the BIO Coronavirus Collaboration Initiative\, which is intended to help connect innovators with partners across both the industry and inside the federal government to combat the coronavirus. \nThe summit will include leaders from biotech and pharmaceutical companies\, global academic experts in virology and immunology\, and non-governmental organizations. Those invited to participate include Ambassador Deborah Birx\, Dr. Robert Kadlec\, and other senior leaders from key government offices\, including the U.S. Department of Defense\, U.S. Department of Health & Human Services\, the Centers for Disease Control and Prevention\, National Institutes of Health\, and the Food and Drug Administration. Information regarding confirmed guests will be provided at a later date. \nAs an international trade association representing more than 700 biotechnology companies\, BIO is playing a unique role in organizing and coordinating the activities of many of its companies. More than 45 member companies are working to address coronavirus and more than 20 have products in various stages of development. \n“Close collaboration between America’s biopharmaceutical companies and the U.S. government is leading the global race to develop vaccines and cures to protect society from the coronavirus\,” said BIO President and CEO Jim Greenwood. “Our researchers and scientists are at the forefront of this important effort\, and they will answer the challenge just as they always have. This virtual summit is a critical step to helping industry leaders\, government officials\, and other vital partners collaborate and ultimately accelerate the development of new medicines to overcome this global threat. BIO is uniquely positioned to help drive this collaboration\, and this is one step in our broader efforts to combat the coronavirus.” \n“Across the biopharmaceutical industry\, men and women are working tirelessly under difficult circumstances to combat the coronavirus\,” said Dr. Scangos.“We are witnessing the true motivation of people in the industry – to do everything we can to bring medicines to people who need them. I am gratified to see people working incredibly hard to bring forward treatments for Covid-19 as quickly as humanly possible. I am pleased to help lead this virtual summit\, which will help facilitate the collaboration and public-private partnerships necessary to treat the sick and prevent further spread of the coronavirus.” \nThe virtual summit will feature presentations and discussions on the latest epidemiologic developments related to the coronavirus\, response work that is underway\, and where critical gaps exist in current R&D and response efforts. The meeting will focus on three key areas of the response: diagnosing the virus\, treating those with the virus\, and preventative measures to contain further transmission of the virus.
URL:https://globalbiodefense.com/event/bio-coronavirus-collaboration-initiative-virtual-summit/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200325T150000
DTEND;TZID=America/New_York:20200325T163000
DTSTAMP:20200325T061035Z
CREATED:20200324T060239Z
LAST-MODIFIED:20200325T061035Z
UID:42230-1585148400-1585153800@globalbiodefense.com
SUMMARY:Responding to COVID-19 Webinar: The Science of Social Distancing
DESCRIPTION:Brought to you by the American Public Health Association and the National Academy of Medicine\, The Science of Social Distancing webinar series will explore the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \n\n\nBrought to you by the American Public Health Association and the National Academy of Medicine\, this webinar series will explore the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \nThe webinar will feature a panel of expert speakers\, including: \n\nNancy Messonnier\, MD — Director\, National Center for Immunization and Respiratory Diseases\, Centers for Disease Control and Prevention\nMarc Lipsitch\, DPhil — Director\, Center for Communicable Disease Dynamics\, Harvard T. H. Chan School of Public Health\nMitch Stripling — National Director\, Emergency Preparedness and Response\, Planned Parenthood and former assistant commissioner of Agency Preparedness and Response for New York City\nHoward Markel\, MD\, PhD — George E. Wantz Distinguished Professor of the History of Medicine and Director of the Center for the History of Medicine\, University of Michigan\n\nThe webinar series will draw from and complement existing advisory activities underway at APHA and the National Academies\, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats\, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19. \nThe series will rapidly and regularly provide trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers\, public health and health care officials\, and the general public. The series will explore the scientific basis for guidance issued by government\, health and public health organizations\, and industry\, as well as answer questions that are top of mind for its audiences.
URL:https://globalbiodefense.com/event/responding-to-covid-19-webinar-the-science-of-social-distancing/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200326
DTEND;VALUE=DATE:20200327
DTSTAMP:20200323T164958Z
CREATED:20200323T164525Z
LAST-MODIFIED:20200323T164958Z
UID:41944-1585180800-1585267199@globalbiodefense.com
SUMMARY:Policy vs. Pandemics: Polarization and Public Health Emergency Preparedness
DESCRIPTION:George Mason University Schar School of Policy and Government Biodefense\, MPP and MPA Programs will co-host a no-fee webinar event\, “Policy vs. Pandemics: Polarization and Public Health Emergency Preparedness” on March 26\, 2020 from 6:00pm – 7:30pm Eastern. \nThe sweeping effects of the on-going COVID-19 pandemic on the social\, economic\, and political framework of the United States highlights the vital importance of a resilient public health infrastructure. In the aftermath of this unprecedented pandemic\, the United States will need to reconsider its approach to biosurveillance\, public health emergency preparedness\, intergovernmental coordination\, and the development of countermeasures in advance of the next health crisis. In the past\, such efforts have been hindered by partisan polarization between Republicans and Democrats\, even as some crucial public health emergency policy was only made possible through bipartisan cooperation. While considering lessons from the past\, this discussion will address bipartisan efforts to move forward on approaches to protect the American people in the future\, such as the implementation of the National Biodefense Strategy. \nDr. Nathan Myers is an associate professor of political science and public administration at Indiana State University. His research interests include public health policy\, U.S. executive branch politics and administration\, emergency planning and preparedness\, and regulation of biotechnology. He is the author of Pandemics and Polarization: Implications of Partisan Budgeting for Responding to Public Health Emergencies (Lexington Books\, 2019). \nDue to the coronavirus pandemic\, this event will be held as a live webinar instead of an in-person talk. Blackboard Collaborate Ultra works best with Google Chrome and does not work with Internet Explorer. Participants will be able to use the “Raise Hand” function in Blackboard Collaborate to ask questions at the end of Dr. Myer’s prepared remarks. \nEveryone who registers for the webinar will receive a 30% discount on his book. \nThis webinar will be recorded and the video will be posted to the YouTube channels for The Pandora Report and the Schar School of Policy and Government . \nIf you have any questions\, please email: biodefense@gmu.edu
URL:https://globalbiodefense.com/event/policy-vs-pandemics-polarization-and-public-health-emergency-preparedness/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200326T130000
DTEND;TZID=America/New_York:20200326T143000
DTSTAMP:20200324T160955Z
CREATED:20200324T160607Z
LAST-MODIFIED:20200324T160955Z
UID:42206-1585227600-1585233000@globalbiodefense.com
SUMMARY:APIC AIHA Webinar - Ventilation\, Surface Disinfection and PPE Considerations for the IP and IH
DESCRIPTION:Amidst the flood of information about the COVID-19 pandemic\, one of the greatest risks is missing key intelligence that can protect health and save lives. This town hall-style webinar\, co-hosted by AIHA and the Association for Professionals in Infection Control and Epidemiology (APIC)\, will address occupational health and safety professionals’\, industrial hygienists’ and infection preventionists’ questions about ventilation\, surface disinfection\, respirators\, construction issues\, occupational health and safety during the COVID-19 pandemic.\nFull webinar description. \nAre you a 2020 Full eLearning Subscriber? This webinar is included in your subscription.\nIf you are purchasing this registration for another person\, please contact the eLearning staff at 1-703-849-8888. \nREGISTRATION INFORMATION\nEach person interested in attending needs their own registration. If you are unable to participate live\, you will have access to the recording for 90 days\, and you’ll be notified via email once the recording is available in the Online Classroom.When registering\, please only register once. Once you checkout\, the system will prompt you to sign in with your AIHA credentials\, or to create a new account. Once you complete either process\, you will checkout\, verify your information\, and confirm your order. \nDue to an increased volume of registrations\, please allow an hour to receive the confirmation message. You may need to check your junk folder.
URL:https://globalbiodefense.com/event/apic-aiha-webinar-ventilation-surface-disinfection-and-ppe-considerations-for-the-ip-and-ih/
LOCATION:Webinar
CATEGORIES:Conference,Training,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200408T140000
DTEND;TZID=America/New_York:20200408T153000
DTSTAMP:20200402T171318Z
CREATED:20200402T170907Z
LAST-MODIFIED:20200402T171318Z
UID:42524-1586354400-1586359800@globalbiodefense.com
SUMMARY:NASEM Webinar: The Supply Chain and COVID-19
DESCRIPTION:COVID-19 has had a profound impact on supply chains for many different critical products worldwide. The pandemic has created major changes in freight flows and has challenged the ability to deliver both medical supplies and food. \nThe National Academies’ Transportation Research Board (TRB) is hosting a webinar on Wednesday\, April 8\, 2020\, from 2:00 to 3:30 PM Eastern that will explore the impacts of COVID-19 on the supply chain and logistics industries. Presenters will discuss lessons learned from past freight transportation and supply chain disruptions\, identify research that has been done to address resilience in the supply chain\, describe how to mitigate the economic impacts of these disruptions\, and provide commentary on current supply chain disruptions due to COVID-19. The webinar is free to attend\, but registration is required. You can follow the conversation on Twitter by using #COVID19 and #TRBwebinar. \nWebinar Participants\n• Moderated by: Mike Meyer\, WSP\, Principal Investigator for NCFRP Research Report 39: Freight Transportation Resilience in Response to Supply Chain Disruptions\n• Paul Bingham\, IHS Markit\, expert in supply chain logistics\, freight transportation\, and transportation economics\n• Anne Strauss-Wieder\, North Jersey Transportation Planning Authority\, expert in supply chain and freight movement\, transportation policy\, and maritime transportation \nWebinar Outline \n1. How the supply chain industry has responded to past disruptions\n2. Lessons learned from past disruptions and best practices for a resilient supply chain\n3. How supply chain and logistics managers can respond to disruptions from COVID-19\n4. Question and answer session\nThe first 60 minutes of the webinar will be for presentations and the final 30 minutes will be reserved for audience questions. \nResources about supply chain and logistics from TRB: \n\nNCFRP Research Report 39: Freight Transportation Resilience in Response to Supply Chain Disruptions\nE-Circular E-C259: International Transportation and Economic Development Conference 2018\nTR News article: Supply Chain Business Continuity\nTR News article: Aviation’s Evolving Role in a Changing Climate\nTRB Director Neil Pedersen’s message regarding COVID-19
URL:https://globalbiodefense.com/event/nasem-webinar-the-supply-chain-and-covid-19/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200415T123000
DTEND;TZID=America/Los_Angeles:20200415T140000
DTSTAMP:20240623T231227Z
CREATED:20200408T174031Z
LAST-MODIFIED:20240623T231227Z
UID:42787-1586953800-1586959200@globalbiodefense.com
SUMMARY:Protecting Older Adults from the Harms of Social Isolation and Providing a Continuum of Care During COVID-19
DESCRIPTION:Join Trust for America’s Health (TFAH) on Wednesday\, April 15th for the webinar Protecting Against the Harms of Social Isolation During COVID-19. \nThe ongoing COVID-19 crisis presents unique challenges for the public health and aging sectors. While social distancing protects older adults who are at higher risk for complications from the virus\, the practice can exacerbate social isolation\, a longstanding issue for this population. \nAttendees will learn about the consequences of social isolation\, how the aging services sector has adapted its delivery models\, promising practices from the field and the importance of working with public health partners to address the needs of older adults.
URL:https://globalbiodefense.com/event/protecting-older-adults-from-the-harms-of-social-isolation-and-providing-a-continuum-of-care-during-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200415T170000
DTEND;TZID=America/New_York:20200415T183000
DTSTAMP:20240623T192248Z
CREATED:20200414T182247Z
LAST-MODIFIED:20240623T192248Z
UID:43055-1586970000-1586975400@globalbiodefense.com
SUMMARY:APHA and National Academy of Medicine Webinar: Crisis Standards of Care During COVID-19
DESCRIPTION:Brought to you by the American Public Health Association and the National Academy of Medicine\, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \nWebinar #4: Crisis Standards of Care During COVID-19\nWednesday\, April 15\, 5-6:30 p.m. ET \nThe fourth COVID-19 Conversations webinar will provide an overview of crisis standards of care during a pandemic\, challenges for adapting such standards to rapidly evolving clinical care guidelines\, practical considerations for state health departments and hospital systems\, and ethical considerations for decision-making while enacting crisis standards of care. \nThe expert panel for this webinar includes: \n\nJohn L. Hick\, MD\, is a faculty emergency physician at Hennepin County Medical Center and an Associate Professor of Emergency Medicine at the University of Minnesota Medical School. He serves as the Associate Medical Director for Hennepin County Medical Services and Medical Director for Emergency Preparedness at HCMC. He is medical advisor to the Minneapolis/St. Paul Metropolitan Medical Response System. He also serves the Minnesota Department of Health as the Medical Director for the Office of Emergency Preparedness and Medical Director for Hospital Bioterrorism Preparedness. He is the founder and past chair of the Minneapolis/St. Paul Metropolitan Health Compact\, a 29-hospital mutual aid and planning group. The regional program was recognized with a $2.5 million competitive HHS preparedness grant in 2007. Hick traveled to Greece as part of a 15-member CDC/HHS team to assist with health care system preparations for the 2004 Summer Olympics. He continues to work with HHS and other agencies on issues of hospital surge capacity planning\, adjusted standards of care in disasters\, and preparedness for nuclear terrorism.\n\n  \n\nRebecca E. Gee\, MD\, is the Secretary of the Louisiana Department of Health\, the state’s largest agency with a budget of $14 billion\, and Gratis Assistant Professor at the LSU Schools of Public Health and Medicine. Her oversight responsibilities include public health and other direct service programs for citizens in needs such as behavioral health\, developmental disabilities\, aging and adult services\, emergency preparedness ad the Medicaid program. Her Medicaid expansion work resulted in an additiona 500\,000+ Louisiana residents being newly insured and the launch of a dashboard to measure access to health care services that has become a national model used in other states. She is an OB/GYN\, trained policy expert and previously served as the director of the Birth Outcomes Initiative\, where she led the charge to decrease infant mortality and prematurity statewide — an effort that in part led to a 25% reduction in infant mortality\, an 85% drop in elective deliveries before 39 weeks and a 10% drop in NICU admissions.\n\n  \n\nJeffrey Kahn\, PhD\, MD\, is the is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics and the inaugural Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy. He is also Professor in the Department of Health Policy and Management of the Johns Hopkins Bloomberg School of Public Health. He works in a variety of areas of bioethics\, exploring the intersection of ethics and health/science policy. Kahn has served on numerous state and federal advisory panels and is currently chair of National Academies of Sciences\, Engineering\, and Medicine’s Board on Health Sciences Policy\, and has previously chaired its committee on the Use of Chimpanzees in Biomedical and Behavioral Research; the committee on Ethics Principles and Guidelines for Health Standards for Long Duration and Exploration Spaceflights; and a committee on the Ethical\, Social\, and Policy Considerations of Mitochondrial Replacement Techniques. He also formerly served as a member of the National Institutes of Health Recombinant DNA Advisory Committee. In addition to committee leadership and membership\, he is an elected member of the National Academy of Medicine and an elected Fellow of The Hastings Center. He was also the founding president of the Association of Bioethics Program Directors. He is a co-principal investigator with Berman Institute faculty member Gail Geller\, ScD\, MHS\, on GUIDE: Genomic Uses in Infectious Disease and Epidemics\, an NIH-funded project to study the largely unexplored ethical\, legal and social implications of genomics as applied to infectious disease.\n\n  \n\nLawrence “Larry” O. Gostin\, JD\, directs the O’Neill Institute for National and Global Health Law and is the founding O’Neil Chair in Global Health Law at Georgetown University. He served as associate dean for research at Georgetown Law from 2004-2008 and is professor of medicine at Georgetown University and professor of public health at Johns Hopkins University. He is director of the World Health Organization Collaborating Center on National and Global Health Law. Among his appointed posts at WHO\, he served on the Director-General’s Advisory Committee on Reforming the World Health Organization\, is on the International Health Regulations Roster of Experts and has served on many WHO expert advisory committees including on the Pandemic Influenza Preparedness Framework and on the WHO/Global Fund Blue Ribbon Expert Panel: The Equitable Access Initiative to develop a global health equity framework. He co-chairs the Lancet Commission on Global Health Law. He served on two global commissions to report on the lessons learned from the 2015 West African Ebola epidemic and was senior advisor to the United Nations Secretary General’s post-Ebola Commission. Gostin also served on the drafting team for the G-17 Summit in Tokyo in 2016\, focusing on global health security and universal health coverage.
URL:https://globalbiodefense.com/event/apha-and-national-academy-of-medicine-webinar-crisis-standards-of-care-during-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200421T130000
DTEND;TZID=Europe/London:20200421T140000
DTSTAMP:20240623T192624Z
CREATED:20200406T161624Z
LAST-MODIFIED:20240623T192624Z
UID:42642-1587474000-1587477600@globalbiodefense.com
SUMMARY:DASA Biosensing Across Wide Areas Phase 2 Launch
DESCRIPTION:Join the Defence and Security Accelerator for a dial-in on 21 April 2020\, 1pm to 2pm. The competition team will provide a short briefing on the Biosensing Across Wide Areas Phase 2 competition followed by an open forum Q&A session. \nOne to Ones\nThere will be two opportunities for One to One dial-in sessions with the competition team: \n\nWednesday 21 April 2020 –  2.30pm to 4pm: Three slots available\nThursday 22 April 2020 – 1pm to 3pm: Four slots available\n\nThese pre-bookable 20 minute one to one slots will be with the competition team to discuss questions specific to your proposal. Slots are on a first come\, first serve basis. \nPlease note: \n\na separate link will be sent to you on your ticket confirmation to register for a one to one slot\ndetails of the dial in will be sent before the meeting commences\nif the event is oversubscribed\, we may place a limitation on the number of attendees from a single organisation\n\n// \nREAD MORE: UK Launches Wide-Area Biosensor Competition
URL:https://globalbiodefense.com/event/dasa-biosensing-across-wide-areas-phase-2-launch/
CATEGORIES:Conference,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/04/97aef6bbedcf01db65e877ee6755e43d.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200520T110000
DTEND;TZID=America/Los_Angeles:20200520T123000
DTSTAMP:20200513T135220Z
CREATED:20200513T135220Z
LAST-MODIFIED:20200513T135220Z
UID:45402-1589972400-1589977800@globalbiodefense.com
SUMMARY:COVID-19 and the Impact on Communities of Color: Our Nation’s Inequities Exposed
DESCRIPTION:The webinar will highlight the disproportionate health and economic impacts the pandemic is having on communities of color and the short- and long-term efforts needed to advance equity in the response to and recovery from the COVID-19 pandemic and future public health emergencies. There will also be a focus on recent federal legislation and state actions in response to COVID-19.
URL:https://globalbiodefense.com/event/covid-19-and-the-impact-on-communities-of-color-our-nations-inequities-exposed/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
END:VCALENDAR